Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

The Global Virome Project.

Carroll D, Daszak P, Wolfe ND, Gao GF, Morel CM, Morzaria S, Pablos-Méndez A, Tomori O, Mazet JAK.

Science. 2018 Feb 23;359(6378):872-874. doi: 10.1126/science.aap7463. No abstract available.

PMID:
29472471
2.

Mapping global policy discourse on antimicrobial resistance.

Wernli D, Jørgensen PS, Morel CM, Carroll S, Harbarth S, Levrat N, Pittet D.

BMJ Glob Health. 2017 Jul 13;2(2):e000378. doi: 10.1136/bmjgh-2017-000378. eCollection 2017.

3.

Preserving the 'commons': addressing the sustainable use of antibiotics through an economic lens.

Morel CM, Edwards SE, Harbarth S.

Clin Microbiol Infect. 2017 Oct;23(10):718-722. doi: 10.1016/j.cmi.2017.08.002. Epub 2017 Aug 12. Review.

4.

Human resources estimates and funding for antibiotic stewardship teams are urgently needed.

Pulcini C, Morel CM, Tacconelli E, Beovic B, de With K, Goossens H, Harbarth S, Holmes A, Howard P, Morris AM, Nathwani D, Sharland M, Schouten J, Thursky K, Laxminarayan R, Mendelson M.

Clin Microbiol Infect. 2017 Nov;23(11):785-787. doi: 10.1016/j.cmi.2017.07.013. Epub 2017 Aug 2. No abstract available.

PMID:
28778544
5.

Ivermectin efficacy against Biomphalaria, intermediate host snail vectors of Schistosomiasis.

Katz N, Araújo N, Coelho PMZ, Morel CM, Linde-Arias AR, Yamada T, Horimatsu Y, Suzuki K, Sunazuka T, Ōmura S.

J Antibiot (Tokyo). 2017 May;70(5):680-684. doi: 10.1038/ja.2017.31. Epub 2017 Mar 15.

PMID:
28293033
6.

Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.

von Dach E, Morel CM, Murthy A, Pagani L, Macedo-Vinas M, Olearo F, Harbarth S.

Clin Microbiol Infect. 2017 Sep;23(9):659-666. doi: 10.1016/j.cmi.2017.02.011. Epub 2017 Feb 20.

7.

The Brazilian Dilemma: Increased Scientific Production and High Publication Costs during a Global Health Crisis and Major Economic Downturn.

Rodrigues ML, Morel CM.

MBio. 2016 Jun 28;7(3). pii: e00907-16. doi: 10.1128/mBio.00907-16. No abstract available.

8.

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.

Outterson K, Gopinathan U, Clift C, So AD, Morel CM, Røttingen JA.

PLoS Med. 2016 Jun 14;13(6):e1002043. doi: 10.1371/journal.pmed.1002043. eCollection 2016 Jun.

9.

Exploring the Obstacles to Implementing Economic Mechanisms to Stimulate Antibiotic Research and Development: A Multi-Actor and System-Level Analysis.

Baraldi E, Ciabuschi F, Leach R, Morel CM, Waluszewski A.

Am J Law Med. 2016 May;42(2-3):451-486. doi: 10.1177/0098858816658276.

PMID:
29086643
10.

Drug Discovery for Paediatric Chagas Disease.

Thota S, Morel CM.

Mini Rev Med Chem. 2015 Jul 21. [Epub ahead of print]

PMID:
26202205
11.

Recent Advances in Synthetic Chemistry of Diabetic Research.

Thota S, Morel CM.

Mini Rev Med Chem. 2015;15(14):1159-63. Review.

PMID:
26202188
12.

Debate on the paper by Guimarães.

Morel CM.

Cad Saude Publica. 2014 Aug;30(8):1598. No abstract available.

13.

Proposal for a telehealth concept in the translational research model.

Silva AB, Morel CM, Moraes IH.

Rev Saude Publica. 2014 Apr;48(2):347-56. Review. English, Portuguese.

14.

The Human Hookworm Vaccine.

Hotez PJ, Diemert D, Bacon KM, Beaumier C, Bethony JM, Bottazzi ME, Brooker S, Couto AR, Freire Mda S, Homma A, Lee BY, Loukas A, Loblack M, Morel CM, Oliveira RC, Russell PK.

Vaccine. 2013 Apr 18;31 Suppl 2:B227-32. doi: 10.1016/j.vaccine.2012.11.034. Review.

15.

Cost-effectiveness of long-lasting insecticide-treated hammocks in preventing malaria in South-central Vietnam.

Morel CM, Thang ND, Erhart A, Xa NX, Peeters Grietens K, Xuan Hung L, Thuan le K, Van Ky P, Hung NM, Coosemans M, D'Alessandro U, Mills A.

PLoS One. 2013;8(3):e58205. doi: 10.1371/journal.pone.0058205. Epub 2013 Mar 11.

16.

Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.

Vasconcellos AG, Morel CM.

PLoS One. 2012;7(10):e45569. doi: 10.1371/journal.pone.0045569. Epub 2012 Oct 3.

17.

The onchocerciasis chronicle: from the beginning to the end?

Crump A, Morel CM, Omura S.

Trends Parasitol. 2012 Jul;28(7):280-8. doi: 10.1016/j.pt.2012.04.005. Epub 2012 May 25. Review.

PMID:
22633470
18.

The level of income appears to have no consistent bearing on pharmaceutical prices across countries.

Morel CM, McGuire A, Mossialos E.

Health Aff (Millwood). 2011 Aug;30(8):1545-52. doi: 10.1377/hlthaff.2010.0317.

PMID:
21821572
19.

Chagas disease: transcriptomic recovery in animal models after transplantation of bone marrow cells.

Morel CM.

Cell Cycle. 2011 Jun 15;10(12):1892. Epub 2011 Jun 15. No abstract available.

PMID:
21577049
20.

Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy.

Remme JHF, Feenstra P, Lever PR, Medici AC, Morel CM, Noma M, Ramaiah KD, Richards F, Seketeli A, Schmunis G, van Brakel WH, Vassall A.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 22.

21.

Stoking the antibiotic pipeline.

Morel CM, Mossialos E.

BMJ. 2010 May 18;340:c2115. doi: 10.1136/bmj.c2115. No abstract available.

PMID:
20483950
22.

Co-authorship network analysis: a powerful tool for strategic planning of research, development and capacity building programs on neglected diseases.

Morel CM, Serruya SJ, Penna GO, Guimarães R.

PLoS Negl Trop Dis. 2009 Aug 18;3(8):e501. doi: 10.1371/journal.pntd.0000501.

23.

The Millennium Development Goals fail poor children: the case for equity-adjusted measures.

Reidpath DD, Morel CM, Mecaskey JW, Allotey P.

PLoS Med. 2009 Apr 28;6(4):e1000062. doi: 10.1371/journal.pmed.1000062. Epub 2009 Apr 28. No abstract available.

24.

The economic burden of malaria on the household in south-central Vietnam.

Morel CM, Thang ND, Xa NX, Hung le X, Thuan le K, Van Ky P, Erhart A, Mills AJ, D'Alessandro U.

Malar J. 2008 Aug 27;7:166. doi: 10.1186/1475-2875-7-166.

25.

The road to recovery.

Morel CM, Carvalheiro JR, Romero CN, Costa EA, Buss PM.

Nature. 2007 Sep 13;449(7159):180-2. No abstract available.

PMID:
17851516
26.

[Innovation in health and neglected diseases].

Morel CM.

Cad Saude Publica. 2006 Aug;22(8):1522-3. Epub 2006 Jul 7. Portuguese. No abstract available.

27.

Cost effectiveness analysis of strategies to combat malaria in developing countries.

Morel CM, Lauer JA, Evans DB.

BMJ. 2005 Dec 3;331(7528):1299. Epub 2005 Nov 10. Erratum in: BMJ. 2006 Jul 8;333(7558):86. BMJ. 2006 Jan 21;332(7534):151.

28.

Health innovation networks to help developing countries address neglected diseases.

Morel CM, Acharya T, Broun D, Dangi A, Elias C, Ganguly NK, Gardner CA, Gupta RK, Haycock J, Heher AD, Hotez PJ, Kettler HE, Keusch GT, Krattiger AF, Kreutz FT, Lall S, Lee K, Mahoney R, Martinez-Palomo A, Mashelkar RA, Matlin SA, Mzimba M, Oehler J, Ridley RG, Senanayake P, Singer P, Yun M.

Science. 2005 Jul 15;309(5733):401-4.

PMID:
16020723
29.

Chagas disease.

Morel CM, Lazdins J.

Nat Rev Microbiol. 2003 Oct;1(1):14-5. No abstract available.

PMID:
15040175
30.

The Anopheles gambiae genome: next steps for malaria vector control.

Touré YT, Oduola AM, Morel CM.

Trends Parasitol. 2004 Mar;20(3):142-9. Review.

PMID:
15036036
31.

Leprosy.

Engers H, Morel CM.

Nat Rev Microbiol. 2003 Nov;1(2):94-5. doi: 10.1038/nrmicro764. No abstract available.

PMID:
15035038
32.
33.

Strategic emphases for tropical diseases research: a TDR perspective.

Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kengeya Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM.

Trends Parasitol. 2002 Oct;18(10):421-6. Review.

PMID:
12377584
34.

Strategic emphases for tropical diseases research: a TDR perspective.

Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM.

Trends Microbiol. 2002 Oct;10(10):435-40.

PMID:
12377547
35.

The mosquito genome--a breakthrough for public health.

Morel CM, Touré YT, Dobrokhotov B, Oduola AM.

Science. 2002 Oct 4;298(5591):79.

PMID:
12364774
36.

Present and future control of malaria.

Morel CM.

Science. 2001 Jan 19;291(5503):435-6. No abstract available.

PMID:
11228137
37.

Reaching maturity - 25 years of the TDR.

Morel CM.

Parasitol Today. 2000 Dec;16(12):522-8. Review.

PMID:
11121849
38.

Polymerase chain reaction detection: new insights into the diagnosis of chronic Chagas disease.

Britto C, Cardoso MA, Marques P, Fernandes O, Morel CM.

Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:305-6. No abstract available.

39.

Chagas disease, from discovery to control - and beyond: history, myths and lessons to take home.

Morel CM.

Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:3-16. No abstract available.

40.

Paleoparasitology: perspectives with new techniques.

Araújo A, Reinhard K, Bastos OM, Costa LC, Pirmez C, Iñiguez A, Vicente AC, Morel CM, Ferreira LF.

Rev Inst Med Trop Sao Paulo. 1998 Nov-Dec;40(6):371-6.

PMID:
10436657
41.

The complexity of the sylvatic cycle of Trypanosoma cruzi in Rio de Janeiro state (Brazil) revealed by the non-transcribed spacer of the mini-exon gene.

Fernandes O, Mangia RH, Lisboa CV, Pinho AP, Morel CM, Zingales B, Campbell DA, Jansen AM.

Parasitology. 1999 Feb;118 ( Pt 2):161-6.

PMID:
10028530
42.

Parasite genome projects and the Trypanosoma cruzi genome initiative.

Degrave W, Levin MJ, da Silveira JF, Morel CM.

Mem Inst Oswaldo Cruz. 1997 Nov-Dec;92(6):859-62.

43.

Trypanosoma cruzi genome project: biological characteristics and molecular typing of clone CL Brener.

Zingales B, Pereira ME, Oliveira RP, Almeida KA, Umezawa ES, Souto RP, Vargas N, Cano MI, da Silveira JF, Nehme NS, Morel CM, Brener Z, Macedo A.

Acta Trop. 1997 Nov;68(2):159-73.

PMID:
9386791
44.

PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis.

Wincker P, Telleria J, Bosseno MF, Cardoso MA, Marques P, Yaksic N, Aznar C, Liegeard P, Hontebeyrie M, Noireau F, Morel CM, Breniere SF.

Parasitology. 1997 Apr;114 ( Pt 4):367-73.

PMID:
9107023
45.

Experimental paleoparasitology: identification of Trypanosoma cruzi DNA in desiccated mouse tissue.

Bastos OM, Araújo A, Ferreira LF, Santoro A, Wincker P, Morel CM.

Paleopathol Newsl. 1996 Jun;(94):5-8.

PMID:
11613235
46.
47.
48.

Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation.

Britto C, Cardoso MA, Vanni CM, Hasslocher-Moreno A, Xavier SS, Oelemann W, Santoro A, Pirmez C, Morel CM, Wincker P.

Parasitology. 1995 Apr;110 ( Pt 3):241-7.

PMID:
7724232
49.

High correlation between Chagas' disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in an endemic area.

Wincker P, Bosseno MF, Britto C, Yaksic N, Cardoso MA, Morel CM, Brenière SF.

FEMS Microbiol Lett. 1994 Dec 15;124(3):419-23.

PMID:
7851750
50.

Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area.

Wincker P, Britto C, Pereira JB, Cardoso MA, Oelemann W, Morel CM.

Am J Trop Med Hyg. 1994 Dec;51(6):771-7.

PMID:
7810810

Supplemental Content

Loading ...
Support Center